Skip to Content
Merck
  • Identification of underlying and transfusion-related platelet qualitative alterations in the hemato-oncologic patient.

Identification of underlying and transfusion-related platelet qualitative alterations in the hemato-oncologic patient.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis (2017-10-04)
Carmen Vicente-Ayuso, Petros Papadopoulos, María Villa-Fajardo, Blanca Prieto, Ana María Álvarez-Carmona, Marta Mateo-Morales, Cristina Pérez-López, Ascensión Peña-Cortijo, Marta Polo-Zarzuela, Isabel Sáez, María Paz Martín, Celina Benavente-Cuesta, Ataúlfo González-Fernández, Rafael Martínez-Martínez, Jaap Jan Zwaginga, Jerard Seghatchian, Laura Gutiérrez
ABSTRACT

Hemato-oncologic patients with chemotherapy-induced thrombocytopenia are one of the populations receiving platelet transfusions. The general practice with these patients is to give prophylactic platelet transfusions when platelet counts fall below 10×10

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Human KIT / Mast/Stem Cell Growth Factor Receptor Kit ELISA Kit